telehealth semaglutide cost comparison TrimRX

Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. Adam

24.07

★★★★☆4.8 (226)

Reports claim that a single well-connected patient received early access to Eli Lilly's experimental weight-loss drug, Retatrutide, through the FDA's compassionate use program before approval. The patient was reportedly 79 years old,

25.20

★★★★★4.8 (226)

Retatrutide, a new weight loss drug not available on the market yet, is showing promising results in trials. @DrLaPook explains it's doing much more than what current medications can

23.89

★★★★★4.1 (94)

The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight-loss results, Retatrutide

22.83

★★★★★4.6 (35)

Triple G pen 20 mg (Reta)

25.37

★★★★★4.9 (251)

Triple G 4 mg PEN

27.55

★★★★★4.5 (148)

Two Years After Stopping GLP-1s, Most Patients Sustain at Least Some Weight Loss

25.85

★★★★★4.3 (188)